OACC - Oaktree Acquisition Corp. II Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

OACC

OAKTREE ACQUISITION CORP. II

NASDAQ

$10.74

▼ DOWN 0.37% (-0.04)

KEY STATISTICS

Market Cap$264.02 M

52w High$10.88

52w Low$10.36

Dividend Yield—

Frequency—

P/E37.03

Volume35.93K

Shares Out.24.58M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Zaid Pardesi

ABOUT

SECTOR

Financial Services

WENT PUBLIC

December 16, 2024

METHOD OF GOING PUBLIC

N/A

FULL TIME EMPLOYEES

PRICE

$10.74 ▼ DOWN 0.37% (−$0.04)

About Oaktree Acquisition Corp. II

https://www.oaktreeacquisitioncorp.com/oac-iii ↗

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.